BBOT vs MDLZ · rev $7.5M vs P/E 30, rev $38.54B
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported BBOT revenue for 2026-06-30 was $7.5M. Net income was -$98.6M. Revenue was up 90.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
BBOT currently screens at market cap $610.4M. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the BBOT and MDLZ stock pages for the full models.
Not investment advice.